WUHAN GENERAL GROUP

M2bio Sciences Inc. formerly Wuhan General Group, Inc. is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms based products under Dr. AnnaRx™, Medspresso™ and Handcrafted Delights™ brands. In addition, our research and clinical trials with psilocybin are aimed for new therapies that will help patients who suffer from alcohol addiction, mental illness and heart diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

WUHAN GENERAL GROUP

Social Links:

Facebook

Twitter

Instagram

Youtube

Industry:

Biotechnology Cannabis Health Care Medical

Founded:

1988-07-19

Address:

Cape Town, NA - South Africa, South Africa

Country:

South Africa

Website Url:

http://www.m2bio.co

Total Employee:

Status:

Active

Email Addresses:

[email protected]

Total Funding:

450 K USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Amazon US Privacy User Signal Mechanism PHP 7 CloudFront Pound Sterling OpenResty

Similar Organizations

arima-genomics-logo

Current Employees Featured

not_available_image

Michael Sachar
Michael Sachar CEO @ Wuhan General Group
CEO
2021-06-01

Founder

not_available_image

Anna Morera Leralta

jeff-robinson_image

Jeff Robinson

not_available_image

Ramy Kamaneh

Stock Details

Company's stock symbol is OTCPINK:WUHN

Acquisitions List

Date	Company	Article	Price
2019-01-01	MJ MedTech	MJ MedTech acquired by Wuhan General Group	N/A

Investors List

threed-capital-inc_image

ThreeD Capital

ThreeD Capital investment in Post-IPO Equity - Wuhan General Group

Key Employee Changes

Date	New article
2021-05-20	Wuhan General Group Appoints Michael Sachar CEO of M2Bio Sciences Food & Beverage

Official Site Inspections

http://www.m2bio.co Semrush global rank: 7.28 M Semrush visits lastest month: 543

Host Informations
Whois Informations

Loading ...